Lecicarbon E Co2-Laxans Drei

Sodium hydrogen carbonate and sodium dihydrogen phosphate, the active ingredient in Lecicarbon E Co2-Laxans Drei, is a laxative presented as a rectal enema solution for rectal use. It helps relieve constipation in adults.

GNH USA supplies Lecicarbon E Co2-Laxans Drei as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards, provides batch‑tested products, and offers logistics support for global distribution. Its reliable supply chain ensures timely availability for patient care across multiple regions.

Lecicarbon E Co2-Laxans Drei, an osmotic laxative, is used to manage constipation by increasing colonic water content. - Constipation: facilitates softer stool and easier passage in adults. - Occasional constipation: provides rapid relief for intermittent bowel irregularities. - Functional constipation: improves bowel frequency in patients with chronic functional bowel disorders.

Adverse reactions are generally mild and related to the rectal route.

Common Side Effects: - Abdominal cramping or discomfort. - Flatulence or bloating. - Mild rectal irritation or burning sensation. - Nausea.

Serious or Rare Side Effects: - Severe abdominal pain. - Electrolyte imbalance (e.g., hypernatremia). - Allergic reaction such as rash or swelling. - Dehydration with excessive use. - Rectal bleeding (rare).

Before using Lecicarbon E Co2-Laxans Drei, consider the following safety measures. - Assess hydration status: ensure the patient is not severely dehydrated. - Avoid in intestinal obstruction: contraindicated if blockage is suspected. - Do not exceed recommended frequency: follow prescriber guidance on repeat dosing. - Monitor for persistent symptoms: seek medical advice if constipation persists beyond 48 hours. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Lecicarbon E Co2-Laxans Drei may interact with other agents that affect fluid or electrolyte balance.

Major Interactions (Avoid): - Concurrent use with high‑dose oral electrolyte solutions may cause severe electrolyte disturbances. - Combination with other osmotic laxatives can increase risk of dehydration and electrolyte loss.

Moderate Interactions (Monitor Closely): - Use with antacids may increase sodium load. - Co‑administration with diuretics may affect overall fluid balance. - Some antibiotics may have altered absorption when given immediately after the enema.